Chimeric Antigen Receptor - AgenTus Therapeutics

An immune cell weaponized with a synthetic receptor (CAR-T) which combines tumor specific targeting capability with T-cell activation to seek out and eradicate cancer.

References

• CAR T-cell therapy: Full speed ahead.
  Sermer D, Brentjens R.
  Hematol Oncol.
  2019 Jun;37 Suppl 1:95-100. PMID: 311875332.

• Switching on the green light for chimeric antigen receptor T-cell therapy.
  Mardiana S, Lai J, House IG, Beavis PA, Darcy PK.
  Clin Transl Immunology.
  2019 May 5;8(5):e1046. PMID: 31073403
  Free PMC Article

• An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer.
  Feins S, Kong W, Williams EF, Milone MC, Fraietta JA.
  Am J Hematol
  2019 May;94(S1):S3-S9. PMID: 30680780

• Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance.
  Boyiadzis MM, Dhodapkar MV, Brentjens RJ, Kochenderfer JN, Neelapu SS, Maus MV, Porter DL, Maloney DG, Grupp SA, Mackall CL, June CH, Bishop MR.
  J Immunother Cancer.
  2018 Dec 4;6(1):137. PMID: 30514386
  Free PMC Article